tradingkey.logo
tradingkey.logo
Search

Unitedhealth Group Inc

UNH
Add to Watchlist
379.980USD
+10.240+2.77%
Close 05/08, 16:00ETQuotes delayed by 15 min
345.02BMarket Cap
28.58P/E TTM

Unitedhealth Group Inc

379.980
+10.240+2.77%
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+2.77%

5 Days

+3.04%

1 Month

+24.18%

6 Months

+17.20%

Year to Date

+15.11%

1 Year

-1.44%

Key Insights

Unitedhealth Group Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 59 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 388.16.In the medium term, the stock price is expected to trend up.Despite strong stock market performance and technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Unitedhealth Group Inc's Score

Industry at a Glance

Industry Ranking
59 / 75
Overall Ranking
239 / 4494
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

46°C

Very Low
Very High
Neutral

Unitedhealth Group Inc Highlights

StrengthsRisks

UnitedHealth Group Incorporated is an American multinational for-profit organization that specializes in health insurance and healthcare services, located in Eden Prairie, Minnesota. Operating under the UnitedHealthcare brand for insurance products and the Optum brand for healthcare services, it is recognized as the world's seventh-largest company by revenue and the largest healthcare corporation by revenue. The company ranks 8th on the 2024 Fortune Global 500 list, with a market capitalization of $460.3 billion as of December 20, 2024. UnitedHealth Group has encountered numerous investigations, lawsuits, and penalties—including SEC enforcement related to stock option backdating, Medicare overbilling, unfair claims practices, denials of mental health treatments, and anticompetitive conduct—illuminating deep-rooted issues of fraud, patient harm, and corporate misconduct.

Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 447.93B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.62% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 52.29%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 52.29%.
Fairly Valued
The company’s latest PE is 28.58, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 768.81M shares, decreasing 0.82% quarter-over-quarter.
Held by Donald Yacktman
Star Investor Donald Yacktman holds 168.46K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.68.

Analyst Rating

Based on 30 analysts
Buy
Current Rating
388.163
Target Price
+4.70%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Unitedhealth Group Inc News

Blue Cross Blue Shield Pays $2.67 Billion Settlement, Why ELV Stock Price Wasn’t Dragged Down?

TradingKey — This month, approximately 6 million people across the U.S. will begin receiving settlement payments averaging about $333 per person. The funds originate from a $2.67 billion antitrust class-action settlement involving the Blue Cross Blue Shield Association (BCBS), following more than a

TradingKeyThu, May 7
TradingKey — This month, approximately 6 million people across the U.S. will begin receiving settlement payments averaging about $333 per person. The funds originate from a $2.67 billion antitrust class-action settlement involving the Blue Cross Blue Shield Association (BCBS), following more than a

UnitedHealth Beats Q1 2026 and Raises Guidance - Is UNH Stock a Buy After Jumping 8%?

UNH beat Q1 EPS by 10% at $7.23, MCR improved to 83.9%, and guidance raised to >$18.25. Stock jumped 8%. Key breakout level $357, targets $380–$407. Buy or wait?

TradingKeyWed, Apr 22
UNH beat Q1 EPS by 10% at $7.23, MCR improved to 83.9%, and guidance raised to >$18.25. Stock jumped 8%. Key breakout level $357, targets $380–$407. Buy or wait?

What Are Defensive Stocks? Best Defensive Stocks to Buy in 2026

TradingKey - Defensives run on resilience: predictable demand, strong cash flow, conservative balance sheets, and tame volatility. You can’t just look at a sector name to find them. It requires a systematic examination of cash generation, leverage, dividend sustainability, beta, competitive moats, a

TradingKeyMon, Mar 16
TradingKey - Defensives run on resilience: predictable demand, strong cash flow, conservative balance sheets, and tame volatility. You can’t just look at a sector name to find them. It requires a systematic examination of cash generation, leverage, dividend sustainability, beta, competitive moats, a

UNH Stock Analysis: UnitedHealth (UNH) Down 50% in 2025 — Buffett Still Holds 45 Million Shares. Time to Buy the Dip?

UnitedHealth Group Stock Analysis: Why has UNH's stock price halved this year? Should investors follow Buffett's lead and continue holding? Will UNH's stock price hit new lows?

TradingKeyFri, Nov 28
UnitedHealth Group Stock Analysis: Why has UNH's stock price halved this year? Should investors follow Buffett's lead and continue holding? Will UNH's stock price hit new lows?

US 13F Filings Flood In: 'Smart Money' Shifts Could Deepen Equity Correction

TradingKey - As US tech stocks grapple with AI bubble concerns and faltering performance, quarterly 13F filings from investment institutions are entering a heavy disclosure period. These reports will unveil "smart money" strategies and could influence future market direction. However, given recent

TradingKeyThu, Nov 13
TradingKey - As US tech stocks grapple with AI bubble concerns and faltering performance, quarterly 13F filings from investment institutions are entering a heavy disclosure period. These reports will unveil "smart money" strategies and could influence future market direction. However, given recent

As Rotation from Tech to Value Gains Steam, Is It Time to Buy the Dow Jones by End-2025?

TradingKey - The Dow Jones Industrial Average has reached successive record highs, and its outperformance against the Nasdaq over the past two days reached the highest level in nine months, signaling an early market style shift from tech to blue-chip or value stocks amid persistent concerns about

TradingKeyThu, Nov 13
TradingKey - The Dow Jones Industrial Average has reached successive record highs, and its outperformance against the Nasdaq over the past two days reached the highest level in nine months, signaling an early market style shift from tech to blue-chip or value stocks amid persistent concerns about

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Unitedhealth Group Inc Info

UnitedHealth Group Incorporated is an American multinational for-profit organization that specializes in health insurance and healthcare services, located in Eden Prairie, Minnesota. Operating under the UnitedHealthcare brand for insurance products and the Optum brand for healthcare services, it is recognized as the world's seventh-largest company by revenue and the largest healthcare corporation by revenue. The company ranks 8th on the 2024 Fortune Global 500 list, with a market capitalization of $460.3 billion as of December 20, 2024. UnitedHealth Group has encountered numerous investigations, lawsuits, and penalties—including SEC enforcement related to stock option backdating, Medicare overbilling, unfair claims practices, denials of mental health treatments, and anticompetitive conduct—illuminating deep-rooted issues of fraud, patient harm, and corporate misconduct.

Ticker SymbolUNH
CompanyUnitedhealth Group Inc
CEONoel (Timothy John)
Websitehttps://www.unitedhealthgroup.com/
KeyAI